Last update June 13, 2021
Very Low Risk
Antidepressant effects similar to other selective serotonin-reuptake inhibitors.
Oral administration once daily.
Its pharmacokinetic data (high percentage of plasma protein binding and high volume of distribution) explain the negligible passage into milk observed (Marshall 2021).
No problems have been observed in infants whose mothers have taken it (Marshall 2021).
It can cause hyperprolactinemia and galactorrhea (Verma 2017).
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM